Skip to main content

REGENXBIO Inc 10-Q for FY2026 Q1

REGENXBIO Inc. (RGNX)

10-Q 2026-05-14 For: 2026-03-31
View Original
Added on May 14, 2026

About this 10-Q

REGENXBIO Inc filed this 10-Q on May 14, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$6.39M
down 92.8% from $89.01M a year earlier
Net loss
$90.05M
compared with net income of $6.08M a year earlier
Diluted EPS
-$1.72
compared with $0.12 a year earlier